Skip to main content
. Author manuscript; available in PMC: 2017 Oct 15.
Published in final edited form as: Cancer. 2016 Jul 5;122(20):3191–3198. doi: 10.1002/cncr.30077

Figure 1.

Figure 1

Chemotherapy use and comorbidity burden (assessed by Charlson Index)

A. By time period: Use of chemotherapy in metastatic colorectal cancer patients with CCI>1 increased over time (14% in 1996 vs 40% after 2004; p<0.05)

B. By age groups: Use of chemotherapy in metastatic colorectal cancer patients with CCI>1 increased in both older and younger patients over time